Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered ...

Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company’s ...

ZERO Prostate Cancer (ZERO) announces the 2026 ZERO Prostate Cancer Advocacy Summit will take place in person at the Hilton Washington, D.C. Capitol Hill, just steps away from the offices of the ...

Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaidZymeworks to retain ...

Shantanu Narayen transformed Adobe from a boxed-software maker into a cloud subscription powerhouse, growing revenue from $3 billion in 2007 to over $21 billion by 2024. Born in Hyderabad and educated ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, February 25, 2026. Let’s ...

On this day in pop culture history, Charles Schulz penned his last comic, Sid and Marty Kroft earned a gold star, and the first patent for a baldness remedy gets awarded.

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

Pfizer reported fourth-quarter revenue and earnings that topped estimates even amid dwindling demand for its Covid products. The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled ...

Patients in a phase 2b trial kept losing weight after switching to monthly dosing of Pfizer’s GLP-1 receptor agonist, providing early validation of the drugmaker’s $10 billion bet on Metsera. The ...